EPIRUS Biopharmaceuticals Buy Hold or Sell Recommendation
| EPRSQDelisted Stock | USD 0.0001 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding EPIRUS Biopharmaceuticals is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell EPIRUS Biopharmaceuticals within the specified time frame.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. Note, we conduct extensive research on individual companies such as EPIRUS and provide practical buy, sell, or hold advice based on investors' constraints. EPIRUS Biopharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
EPIRUS |
Execute EPIRUS Biopharmaceutica Buy or Sell Advice
The EPIRUS recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on EPIRUS Biopharmaceuticals. Macroaxis does not own or have any residual interests in EPIRUS Biopharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute EPIRUS Biopharmaceutica's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
EPIRUS Biopharmaceutica Trading Alerts and Improvement Suggestions
| EPIRUS Biopharmaceutica is not yet fully synchronised with the market data | |
| EPIRUS Biopharmaceutica has some characteristics of a very speculative penny stock | |
| EPIRUS Biopharmaceutica has a very high chance of going through financial distress in the upcoming years | |
| EPIRUS Biopharmaceuticals has accumulated 14.85 M in total debt with debt to equity ratio (D/E) of 0.57, which is about average as compared to similar companies. EPIRUS Biopharmaceuticals has a current ratio of 0.77, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist EPIRUS Biopharmaceutica until it has trouble settling it off, either with new capital or with free cash flow. So, EPIRUS Biopharmaceutica's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like EPIRUS Biopharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for EPIRUS to invest in growth at high rates of return. When we think about EPIRUS Biopharmaceutica's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 701 K. Net Loss for the year was (52.19 M) with profit before overhead, payroll, taxes, and interest of 576 K. | |
| EPIRUS Biopharmaceuticals has accumulated about 20.86 M in cash with (46.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
EPIRUS Biopharmaceutica Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as EPIRUS . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About EPIRUS Biopharmaceutica Buy or Sell Advice
When is the right time to buy or sell EPIRUS Biopharmaceuticals? Buying financial instruments such as EPIRUS Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having EPIRUS Biopharmaceutica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corona Opportunity Thematic Idea Now
Corona Opportunity
Firms that are involved in some capacity in making products or providing services to the public to buttle the virus directly or indirectly. This also includes some defencive and contrarian stocks and ETFs that are managing to avoid the big market correction coused by coronavirus. The Corona Opportunity theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corona Opportunity Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in EPIRUS Pink Sheet
If you are still planning to invest in EPIRUS Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EPIRUS Biopharmaceutica's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stocks Directory Find actively traded stocks across global markets |